Skip to main content
. 2016 Nov 30;232(6):1571–1578. doi: 10.1002/jcp.25685

Figure 3.

Figure 3

Progression‐free survival (PFS, A) and overall survival (OS,B) in hormone‐receptor positive patients according administration of hormonal therapy (ET) at the end of first‐line chemotherapy.